Sclerotherapy is commonly indicated for telangiectasias and reticular veins

https://orcid.org/0009-0009-2113-9064

Sclerotherapy is commonly indicated for telangiectasias and reticular veins, delivering targeted therapy that avoids surgical incisions and limits scarring compared to more invasive vein procedures.